| Dr Elaine Yu, OD | |
|
661 N Euclid St, Anaheim, CA 92801-4622 | |
| (714) 817-0606 | |
| Not Available |
| Full Name | Dr Elaine Yu |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 661 N Euclid St, Anaheim, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699325027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 34447TLG (California) | Primary |
| Provider Name | Paul S Crismon O D Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568666824 PECOS PAC ID: 8628052859 Enrollment ID: O20040615001880 |
News Archive
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The House Science and Technology Committee has introduced legislation that highlights the growing attention on Capitol Hill to the need to strengthen federal efforts to learn more about the potential environmental, health and safety (EHS) risks posed by engineered nanomaterials.
A look at the initial editorials and opinions on the budget proposal released Tuesday by the House Budget Committee chairman.
CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications.
› Verified 7 days ago
| Provider Name | Dr. Michael S. Chang O.d. Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952573982 PECOS PAC ID: 0345325973 Enrollment ID: O20080306000701 |
News Archive
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The House Science and Technology Committee has introduced legislation that highlights the growing attention on Capitol Hill to the need to strengthen federal efforts to learn more about the potential environmental, health and safety (EHS) risks posed by engineered nanomaterials.
A look at the initial editorials and opinions on the budget proposal released Tuesday by the House Budget Committee chairman.
CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elaine Yu, OD 661 N Euclid St, Anaheim, CA 92801-4622 Ph: (714) 817-0606 | Dr Elaine Yu, OD 661 N Euclid St, Anaheim, CA 92801-4622 Ph: (714) 817-0606 |
News Archive
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.
The House Science and Technology Committee has introduced legislation that highlights the growing attention on Capitol Hill to the need to strengthen federal efforts to learn more about the potential environmental, health and safety (EHS) risks posed by engineered nanomaterials.
A look at the initial editorials and opinions on the budget proposal released Tuesday by the House Budget Committee chairman.
CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications.
› Verified 7 days ago
Tina Do Optometry, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-956-2785 | |
Dr. Derek Kwon Optometry, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 731 N Euclid St, Anaheim, CA 92801 Phone: 714-533-8240 | |
Krupa J Patel, OD Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7569 | |
Dr. Garrett Scott Wada, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 936 S Brookhurst St, Anaheim, CA 92804 Phone: 714-533-2525 Fax: 714-242-9564 | |
Ely R Almaleh, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 441 N Lakeview Ave, Anaheim, CA 92807 Phone: 888-988-2800 | |
Steven Hoffman, Optometrist Medicare: Medicare Enrolled Practice Location: 5460 E La Palma Ave, Anaheim, CA 92807 Phone: 714-463-7500 Fax: 714-992-7850 | |
Ms. Teresa Xuan Do, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 500 S Euclid St Ste D, Anaheim, CA 92802 Phone: 714-635-1100 Fax: 714-635-1155 |